Nirsevimab (Beyfortus)

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending…

Immune Dysregulation (Lambert 2023)

At the end of this session, learners will be able to understand the role of immune dysregulation in common disorders in classical hematology, describe mechanisms…

Lupus Nephritis

At the end of this session, learners will be able to define and diagnose lupus nephritis (LN), classify LN on a renal biopsy, and manage…

Urticaria and Angioedema

At the end of this session, learners will be able to define urticaria and angioedema and the specific pathways for diagnosis and treatment. This session…

Asthma Management

At the end of this session, learners will be able to discuss asthma in pediatric patients, recall the principles and goals in asthma management, and…

Asthma Mimickers (Ruffner 2023)

At the end of this session, learners will be able to define asthma, develop a differential diagnosis for respiratory complaints such as cough, wheeze, and…

Definitive Therapies for Immunodeficiency

At the end of this session, learners will be able to understand definitive therapies for immunodeficiency and the workflow for utilization of definitive therapies with…